ArticleInvestigational new drugs2022

Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.

Yuka Hayakawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.